Replies to post #114014 on Biotech Values

[genisi]

PDSV/ALIM Iluvien

It's not like efficacy is their only problem. Safety issues - high rate of cataract and IOP are also (not surprisingly) there.

[pcrutch]

$PSDV / $ALIM -- they seem love to play this game of pooling the data from their trials. Not sure how valid that is without looking very close. Sold for a small loss; small speculative bet on my part.